Today: 1 May 2026
Browse Category

Stock Market 8 January 2026

Abivax stock slides 9% after Sofinnova flags $134m sale plan, with 2026 trial clock ticking

Abivax stock slides 9% after Sofinnova flags $134m sale plan, with 2026 trial clock ticking

Abivax shares fell 9.49% to 99.20 euros in Paris on Thursday, reversing a 6% gain from the previous day. Volume reached about 246,000 shares amid anticipation of Phase 3 trial results for obefazimod in late Q2 2026. A U.S. Form 144 filing showed Sofinnova Crossover I SLP intends to sell up to 1,000,000 ADS. BTIG raised its price target on Abivax to $150 and maintained a “Buy” rating.
8 January 2026
·
Exxon Mobil stock (XOM) rises as filing flags Q4 upstream hit from weaker crude; Jan 30 next

Exxon Mobil stock (XOM) rises as filing flags Q4 upstream hit from weaker crude; Jan 30 next

Exxon Mobil shares rose 3.3% to $122.42 by early afternoon Thursday after the company warned that lower crude prices could cut fourth-quarter upstream earnings by $0.8 billion to $1.2 billion from the prior quarter. Exxon said stronger refining margins may add $0.3 billion to $0.7 billion. The company reports results Jan. 30. Traders are watching oil price swings and estimate changes.
8 January 2026
···
Teleflex (TFX) stock dives on CEO exit and revenue forecast cut — what investors watch next

Teleflex (TFX) stock dives on CEO exit and revenue forecast cut — what investors watch next

Teleflex shares fell 11.7% to $111.76 Thursday after the company announced CEO Liam Kelly’s exit and cut its 2025 revenue forecast. Stuart Randle was named interim chief executive, with a $140,000 monthly stipend and $1.5 million in stock. Teleflex cited weak demand for balloon pumps and OEM order delays. The company expects to report full results in late February or early March.
8 January 2026
·
Why Applied Optoelectronics (AAOI) stock is down today as tech pulls back

Why Applied Optoelectronics (AAOI) stock is down today as tech pulls back

Applied Optoelectronics (AAOI.O) dropped 14.9% to $32.40 in Thursday afternoon trading, with 6.2 million shares traded and an intraday low of $31.70. The decline followed a broader selloff in tech stocks, leaving the Nasdaq down 0.5% midday. Optical networking peers Ciena, Lumentum, and Coherent also fell sharply. Investors are watching Friday’s U.S. payrolls report and AAOI’s earnings update in late February.
8 January 2026
··
Silver price stock SLV slides as index rebalance selling kicks in ahead of U.S. jobs report

Silver price stock SLV slides as index rebalance selling kicks in ahead of U.S. jobs report

iShares Silver Trust dropped 3.5% to $68.50 in midday New York trading, tracking a broader selloff in silver assets as spot silver fell 2.5% to $76.19 an ounce. Traders cited commodity index rebalancing and a stronger dollar ahead of Friday’s U.S. payrolls report. Silver miners slipped less, down 0.4% to 1%. Sterling weakened for a third day as the dollar firmed.
8 January 2026
······
Dow Jones ETF DIA rises as tech slips and Trump defense headlines jar Wall Street before payrolls

Dow Jones ETF DIA rises as tech slips and Trump defense headlines jar Wall Street before payrolls

The SPDR Dow Jones Industrial Average ETF Trust rose 0.6% to $492.73 Thursday as the Dow climbed 304 points, while the Nasdaq slipped on tech losses. Weekly jobless claims increased to 208,000 and continuing claims reached 1.914 million. Defense stocks rebounded after President Trump proposed a $1.5 trillion military budget for 2027. Investors await Friday’s U.S. nonfarm payrolls report.
8 January 2026
··
Regencell Bioscience (RGC) stock slides about 18% after five volatility halts on Nasdaq

Regencell Bioscience (RGC) stock slides about 18% after five volatility halts on Nasdaq

Regencell Bioscience shares plunged 18.5% to $43.10 Thursday after hitting $69.97 earlier in the session, triggering five volatility halts. Over 3 million shares traded by early afternoon, far above average. The company has warned of “substantial doubt” about its ability to continue operating and reported net losses of $3.58 million for the year ended June 2025. No company statement explained the sharp swings.
8 January 2026
··
Why Westlake stock is jumping today after its ACI deal filing

Why Westlake stock is jumping today after its ACI deal filing

Westlake Corp shares rose 7.4% to $79.98 Thursday after the company said it completed its acquisition of ACI/Perplastic Group’s global compounding solutions businesses. The deal expands Westlake’s manufacturing into Portugal, Romania, and Tunisia. Financial terms were not disclosed. Other major U.S. chemical stocks also gained.
8 January 2026
·
UnitedHealth Group Incorporated stock rises as House summons insurer CEOs; investors eye two January dates

UnitedHealth Group Incorporated stock rises as House summons insurer CEOs; investors eye two January dates

UnitedHealth shares rose 1.3% to $346.11 after U.S. House lawmakers called major health insurer CEOs to testify on coverage affordability January 22. Senators Wyden and Warren accused UnitedHealth of withholding documents in a nursing-home probe, setting a January 28 deadline. TPG is in advanced talks to buy UnitedHealth’s Optum UK unit for up to £1.4 billion, Sky News reported.
8 January 2026
····
IREN stock jumps nearly 8% as AI data-center trade returns; earnings are the next test

IREN stock jumps nearly 8% as AI data-center trade returns; earnings are the next test

IREN shares jumped 7.7% to $46.99 in Thursday afternoon trading, tracking gains in data-center stocks after Applied Digital announced talks with a major cloud customer. IREN operates U.S. and Canadian data centers for bitcoin mining and AI compute, with about 1,896 Nvidia GPUs. Its $9.7 billion, five-year GPU cloud deal with Microsoft includes strict delivery terms. Next results are expected in February, with focus on GPU rollout and funding.
8 January 2026
····
AbbVie stock drops after Revolution deal denial, $1.3 billion charge spooks traders

AbbVie stock drops after Revolution deal denial, $1.3 billion charge spooks traders

AbbVie shares fell 3.7% to $224.84 Thursday after the company denied takeover talks with Revolution Medicines and flagged a $1.3 billion fourth-quarter charge tied to R&D and milestone payments. AbbVie trimmed its 2025 profit forecast, setting adjusted earnings at $9.90 to $9.94 per share. Revolution Medicines dropped 5.5%. Wolfe Research downgraded AbbVie, citing limited upside.
8 January 2026
··
Nebius (NBIS) stock bounces back near $100 as Nvidia Rubin talk keeps AI cloud names jumpy

Nebius (NBIS) stock bounces back near $100 as Nvidia Rubin talk keeps AI cloud names jumpy

Nebius shares rose nearly 4% to $100.03 in midday Nasdaq trading Thursday after the AI cloud company announced plans to offer early access to Nvidia’s Rubin platform starting in the second half of 2026. The stock rebounded after a previous session drop, while Nvidia slipped 2%. Investors are watching a Jan. 29 product webinar and the company’s next earnings update in mid-February.
8 January 2026
····
AeroVironment stock jumps as Trump’s $1.5T defense budget call lifts AVAV

AeroVironment stock jumps as Trump’s $1.5T defense budget call lifts AVAV

AeroVironment shares jumped about 7% to $340.20 Thursday after Donald Trump proposed a $1.5 trillion U.S. military budget for 2027. Defense stocks broadly gained, with the S&P aerospace and defense sub-index hitting a record high. Investors are watching for details on the budget and AeroVironment’s next earnings. About 2.26 million AeroVironment shares changed hands by early afternoon.
8 January 2026
··
1 … 633 634 635 636 637 … 1,404

Stock Market Today

  • Cleveland-Cliffs (CLF) Shares Show Volatile Swings Amid Valuation Debate
    April 30, 2026, 10:01 PM EDT. Cleveland-Cliffs (CLF) stock surged 12% over the past week and nearly 21% in a month, yet it posted a 25.87% decline over 90 days amid mixed long-term returns. Trading around $10.20, the steel and iron ore miner remains about 22% undervalued against a $13.08 fair value estimate from Simply Wall St's model, which factors in cost cuts and tariff impacts. The company reported $18.9 billion in revenue but a $1.2 billion loss, raising questions over its earnings outlook amid industry and regulatory uncertainties such as potential tariff changes. Investors weighing CLF's prospects must consider its cost-saving initiatives and potential risks from decarbonization pressures on its blast furnace operations. The stock's valuation hinges on assumptions around margin improvements and future earnings multiples, with a 12.33% discount rate applied in the current model.

Latest article

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

30 April 2026
Nvidia shares dropped 4.6% to $199.57 Thursday as investors reacted to Alphabet and Amazon expanding sales of their own AI chips. Alphabet reported Google Cloud revenue up 63% and began selling TPU chips directly to customers. AMD and Broadcom shares rose 5.1% and 3.0%, respectively. Amazon said its Trainium chip line secured $225 billion in revenue commitments.
Go toTop